Serina Therapeutics, Inc. (SER)

NYSEAMERICAN: SER · Real-Time Price · USD

4.808

-0.082 (-1.68%)

Oct 17, 2025, 4:00 PM EDT - Market closed

Serina Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 17, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	51	47	-	-	-
Enterprise Value	45	55	-	-	-
Last Close Price	4.81	5.01	-	-	-
PS Ratio	389.73	840.25	-	-	-
PB Ratio	30.78	92.63	-	-	-
P/TBV Ratio	-	73.41	-	-	-
EV/Sales Ratio	346.05	990.71	-	-	-
Debt / Equity Ratio	0.22	0.91	0.90	-0.77	1.19
Asset Turnover	0.01	0.01	0.64	0.44	-
Quick Ratio	1.70	1.55	5.39	1.22	3.53
Current Ratio	2.24	2.40	5.39	1.25	3.58
Return on Equity (ROE)	-	-485.36%	594.25%	-	-
Return on Assets (ROA)	-132.37%	-124.04%	-19.46%	-105.01%	-
Return on Capital (ROIC)	-	-221.85%	-26.28%	-1390.61%	-
Earnings Yield	-25.08%	-23.68%	-	-	-
FCF Yield	-30.94%	-36.47%	-	-	-
Buyback Yield / Dilution	-138.29%	-0.11%	-242.70%	-0.01%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q